Qi Zeng

Biopolis Drive
Proteos, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

PRL3-zumab cancer immunotherapy shows promise for treating neovascular eye diseases.

PRL3-zumab cancer immunotherapy shows promise for treating neovascular eye diseases.

Journal: Expert opinion on investigational drugs

Published: February 06, 2026

Automatic probe guidance for volumetric liver ultrasound acquisition via imitation learning from a virtual expert.

Automatic probe guidance for volumetric liver ultrasound acquisition via imitation learning from a virtual expert.

Journal: International journal of computer assisted radiology and surgery

Published: January 15, 2026

Three-dimensional quantitative elastography using micro-ultrasound: Proof of concept.

Three-dimensional quantitative elastography using micro-ultrasound: Proof of concept.

Journal: Ultrasonics

Published: May 20, 2025

Advances in automated fetal brain MRI segmentation and biometry: Insights from the FeTA 2024 challenge.

Advances in automated fetal brain MRI segmentation and biometry: Insights from the FeTA 2024 challenge.

Journal: Medical image analysis

Published: May 07, 2025

The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy.

The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy.

Journal: Cell reports. Medicine

Published: December 18, 2024

FetDTIAlign: A deep learning framework for affine and deformable registration of fetal brain dMRI.

FetDTIAlign: A deep learning framework for affine and deformable registration of fetal brain dMRI.

Journal: NeuroImage

Published: October 04, 2024

Towards automatic US-MR fetal brain image registration with learning-based methods.

Towards automatic US-MR fetal brain image registration with learning-based methods.

Journal: NeuroImage

Published: October 01, 2024

PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases.

PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases.

Journal: Nature communications

Published: February 28, 2024

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.

Journal: Theranostics

Published: December 11, 2023

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.

Journal: Molecular therapy oncolytics

Published: April 19, 2023

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Journal: Targeted oncology

Published: March 24, 2023

Towards transcervical ultrasound image guidance for transoral robotic surgery.

Towards transcervical ultrasound image guidance for transoral robotic surgery.

Journal: International journal of computer assisted radiology and surgery

Published: March 14, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026